Treatment Therapies in Pancreatic Carcinoma

Pancreatic cancer is the fourth leading cause of cancer deaths, being responsible for 7% of all cancer-related deaths in both men and women. Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occurs in the body of the pancreas, and 5-10% occurs in the tail. Scientists are learning more about some of the changes in DNA that cause cells in the pancreas to become cancerous. Inherited changes in genes such as BRCA2, p16, and the genes responsible for hereditary non-polyposis colorectal cancer (HNPCC) can increase a person’s risk of developing pancreatic cancer.

  • Proton therapy
  • Radiation therapy
  • Chemotherapy
  • Immunotherapy
  • Ablation or embolization treatments

Related Conference of Treatment Therapies in Pancreatic Carcinoma

September 11-12, 2017

12th Euro-Global Gastroenterology Conference

Paris, France
September 13-14, 2017
10 Plenary Forums - 1Event

2nd International Conference on Pancreatic Disorders and Treatment
(10 Plenary Forums - 1Event)

Dallas, Texas, USA
October 16-18, 2017

2nd World Summit on Metabolic Disorders

Chicago, Illinois, USA
December 07-08, 2017

2nd International Conference on Digestive Diseases

Madrid, Spain
December 14-15, 2017

11th World Gastroenterologists Summit

Dubai, UAE
March 19-20, 2018

12th Global
Gastroenterologists Meeting

Barcelona, Spain
April 09-11, 2018

12th International Conference on Abdominal Imaging and Endoscopy

Amsterdam, Netherlands
April 09-11, 2018

6th World Congress on Hepatitis & Liver Diseases

Amsterdam, Netherlands
May 28-29, 2018

6th International Conference on Hepatology

Osaka, Japan

Treatment Therapies in Pancreatic Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in